Mouse strain differences in immobility and sensitivity to fluvoxamine and desipramine in the forced swimming test: Analysis of serotonin and noradrenaline transporter (cas 136253-20-8) binding
-
Add time:09/08/2019 Source:sciencedirect.com
Strain differences in immobility time in the forced swimming test were investigated in five strains of mice, namely, ICR, ddY, C57BL/6, DBA/2 and BALB/c mice. There were significant strain differences. The immobility times of ICR, ddY and C57BL/6 mice were longer than those of DBA/2 and BALB/c mice. Immobility times were not significantly related to locomotor activity in these strains. There were also differences in sensitivity to the selective serotonin reuptake inhibitor (SSRI) fluvoxamine. In ICR, ddY and C57BL/6 mice, fluvoxamine did not affect immobility time, while it reduced the immobility time of DBA/2 and BALB/c mice dose-dependently. The noradrenaline reuptake inhibitor desipramine decreased immobility time in all strains of mice. Serotonin (5-HT) transporter binding in the brains of all five strains of mice was also investigated. Analysis of 5-HT transporter binding revealed significant strain differences, being lower in DBA/2 and BALB/c mice than in other strains of mice. The amount of 5-HT transporter binding was correlated to baseline immobility time. However, there was no significant relation between noradrenaline transporter (cas 136253-20-8) binding and immobility time. These results suggest that the duration of baseline immobility depends on the levels of 5-HT transporter binding, leading to apparent strain differences in immobility time in the forced swimming test. Furthermore, differences in 5-HT transporter binding may cause variations in responses to fluvoxamine.
We also recommend Trading Suppliers and Manufacturers of noradrenaline transporter (cas 136253-20-8). Pls Click Website Link as below: cas 136253-20-8 suppliers
Prev:Differential adaptive changes on serotonin and noradrenaline transporter (cas 136253-20-8)s in a rat model of peripheral neuropathic pain
Next:ArticleSplit-miniSOG for Spatially Detecting Intracellular Protein-Protein Interactions by Correlated Light and Electron Microscopy) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Differential adaptive changes on serotonin and noradrenaline transporter (cas 136253-20-8)s in a rat model of peripheral neuropathic pain09/07/2019
- Short communicationAltered cardiac gene expression of noradrenaline enzymes, transporter and β-adrenoceptors in rat model of rheumatoid arthritis09/06/2019
- noradrenaline transporter (cas 136253-20-8) and its turnover rate are decreased in blood lymphocytes of patients with major depression09/05/2019
- Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter (cas 136253-20-8)09/04/2019
- Design and synthesis of (2R,3S)-iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter (cas 136253-20-8)09/03/2019
- The noradrenaline transporter (cas 136253-20-8) as site of action for the anti-Parkinson drug amantadine09/02/2019
- noradrenaline transporter (cas 136253-20-8) blockade increases fronto-parietal functional connectivity relevant for working memory09/01/2019
- New iodoreboxetine analogues for SPECT imaging of the noradrenaline transporter (cas 136253-20-8)08/31/2019
- The association between in vivo central noradrenaline transporter (cas 136253-20-8) availability and trait impulsivity08/30/2019


